InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Brigido Stephen, Pres., Functional Regeneration. Director active across 1 company, notably Celularity Inc. Cumulatively, 9 reports have been logged. History available since 13 April 2023. The latest transaction was filed on 13 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Stephen Brigido is the President of Functional Regeneration at Celularity Inc. He oversees regeneration and innovation initiatives within the company. His role is essential in developing new solutions.